Biotech Stocks Technical Data -- Research on Navidea Biopharma, Alkermes, Nanosphere, and Organovo Holdings - WSFX - FOX Wilmington, NC

Biotech Stocks Technical Data -- Research on Navidea Biopharma, Alkermes, Nanosphere, and Organovo Holdings

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Investor-Edge

Editor Note: For more information about this release, please scroll to bottom.

LONDON, June 10, 2014 /PRNewswire/ --

The US markets on Monday, June 9, 2014 ended on a higher note as the Dow Jones Industrial Average finished at 16,943.10, up 0.11% and the NASDAQ Composite closed at 4,336.24, up 0.34%. The S&P 500 finished the session 0.09% higher at 1,951.27. During the trading session, six out of ten sectors finished on a positive note. The S&P 500 Health Care Sector Index ended the day at 691.34, down 0.48%, whereas the index has advanced 3.44% in the last one month. Investor-Edge has initiated coverage on the following equities: Navidea Biopharmaceuticals Inc. (NYSE MKT: NAVB), Alkermes PLC (NASDAQ: ALKS), Nanosphere Inc. (NASDAQ: NSPH) and Organovo Holdings Inc. (NYSE MKT: ONVO). Free technical research on NAVB, ALKS, NSPH and ONVO can be downloaded upon signing up at:

http://www.investor-edge.com/3630-register

On Monday, shares in Navidea Biopharmaceuticals Inc. recorded a trading volume of 1.12 million shares, higher than its three months average volume of 0.93 million shares. The stock ended the day at $1.77, which was 2.31% above its previous day's closing of $1.73, and registered an intraday range of $1.71 and $1.77. Although Navidea Biopharmaceuticals Inc.'s stock has lost 14.49% on YTD basis, it has surged 10.63% in the previous three trading sessions and 32.09% in the last one month and. The stock is trading above its 50-day moving average of $1.63, while the 50-day moving average is below its 200-day moving average of $1.99. Furthermore, shares of Navidea Biopharmaceuticals Inc. have a Relative Strength Index (RSI) of 60.35. Sign up today to read free research on NAVB at:

http://www.investor-edge.com/3630-NAVB-10Jun2014.pdf

Alkermes PLC's stock finished the Monday's session 0.12% lower at $48.32. A total of 0.68 million shares were traded, which was below its three months average volume of 1.26 million shares. The stock vacillated between $47.65 and $48.53 during the session. Over the last one month and over the previous three months, Alkermes PLC's shares have advanced 9.49% and 4.32%, respectively. Additionally, from the beginning of 2014, the company's stock has gained an upside of 18.84%. The stock is trading above its 50-day and 200-day moving averages of $45.08 and $41.66, respectively. Alkermes PLC's stock traded at a PE ratio of 920.68 and has an RSI of 63.17. Sign up today to read free research on ALKS at:

http://www.investor-edge.com/3630-ALKS-10Jun2014.pdf

On Monday, Nanosphere Inc.'s stock fluctuated between $1.25 and $1.37 before ending the session 5.51% higher at $1.34. The stock reported a trading volume of 0.88 million shares, above its three months average volume of 0.71 million shares. Nanosphere Inc.'s shares have surged 8.94% in the previous three trading sessions, while the stock has lost 6.94% in the last one month and 41.48% on YTD basis. The company's shares are trading below their 50-day and 200-day moving averages. Moreover, the stock's 200-day moving average of $2.07 is greater than its 50-day moving average of $1.69. Shares of Nanosphere Inc. have an RSI of 30.02. Sign up today to read free research on NSPH at:

http://www.investor-edge.com/3630-NSPH-10Jun2014.pdf

Organovo Holdings Inc.'s stock fell 1.17%, to close the day at $7.63. The stock recorded a trading volume of 0.76 million shares, below its three months average volume of 1.59 million shares. The stock oscillated between $7.51 and $7.94 during the session. Over the last three trading sessions and over the past one month, Organovo Holdings Inc.'s shares have gained 3.53% and 23.06%, respectively. However, the stock has lost 31.07% since the start of this year. The company's stock is trading above its 50-day moving average $6.86, while its 200-day moving average of $7.97 is above the 50-day moving average. Additionally, shares in Organovo Holdings Inc.'s have an RSI of 65.43. Sign up today to read free research on ONVO at:

http://www.investor-edge.com/3630-ONVO-10Jun2014.pdf


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

http://www.investor-edge.com

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and WSFX. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.
FCC Public File
Email: publicfile@wsfx.com
Phone: (910) 791-8070
EEO Report
Closed Captioning